Molecular and genomic characterization of invasive circulating tumor cells (iCTCs) from men with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Friedlander, Terence W.
Premasekharan, Gayatri
Ngo, Vy
Hang, Evelyn
Graff, Julie Nicole
Ryan, Charles J.
Paris, Pamela
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Med Ctr, San Francisco, CA USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland VA Med Ctr, Portland, OR 97201 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.11013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11013
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer
    Magbanua, Mark Jesus M.
    Sosa, Eduardo V.
    Scott, Janet H.
    Simko, Jeff
    Collins, Colin
    Pinkel, Dan
    Ryan, Charles J.
    Park, John W.
    BMC CANCER, 2012, 12
  • [32] Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer
    Mark Jesus M Magbanua
    Eduardo V Sosa
    Janet H Scott
    Jeff Simko
    Colin Collins
    Dan Pinkel
    Charles J Ryan
    John W Park
    BMC Cancer, 12
  • [33] Combining molecular and functional imaging in metastatic castration-resistant prostate cancer (mCRPC).
    Conteduca, Vincenza
    Scarpi, Emanuela
    Wetterskog, Daniel
    Caroli, Paola
    Romanel, Alessandro
    Lolli, Cristian
    Jayaram, Anuradha
    Gurioli, Giorgia
    Brighi, Nicole
    Poti, Giulia
    Wingate, Anna
    Schepisi, Giuseppe
    Matteucci, Federica
    Paganelli, Giovanni
    Demichelis, Francesca
    Attard, Gerhardt
    De Giorgi, Ugo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [34] Molecular characterization of circulating tumor cells (CTC) and CTC. subpopulations in baseline and progressive metastatic castration resistant prostate cancer (mCRPC)
    Dittamore, Ryan
    Louw, Jessica
    Krupa, Rachel
    Danila, Daniel Costin
    Arslan, Zaina
    Schreiber, Nicole A.
    Bales, Natalee
    Marrinucci, Dena
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC).
    Maughan, Benjamin Louis
    Suzman, Daniel L.
    Nadal, Rosa
    Bassi, Sunakshi
    Schweizer, Michael Thomas
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [36] Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients
    Lozano, Rebeca
    Lorente, David
    Aragon, Isabel M.
    Romero-Laorden, Nuria
    Nombela, Paz
    Mateo, Joaquim
    Reid, Alison H. M.
    Cendon, Ylenia
    Bianchini, Diletta
    Llacer, Casilda
    Sandhu, Shahneen K.
    Sharp, Adam
    Rescigno, Pasquale
    Garces, Teresa
    Pacheco, Maria I.
    Flohr, Penelope
    Massard, Christophe
    Lopez-Casas, Pedro P.
    Castro, Elena
    de Bono, Johann S.
    Olmos, David
    CANCERS, 2021, 13 (10)
  • [37] Body composition and clinical outcomes in men with metastatic castration-resistant prostate cancer (mCRPC)
    Hahn, A. W.
    Tidwell, R. S.
    Surasi, D. S.
    Msaouel, P.
    Efstathiou, E.
    Zurita-Saavedra, A. J.
    Tu, S-M.
    McQuade, J. L.
    Fogelman, D.
    Starbuck, M. W.
    Subudhi, S. K.
    Corn, P.
    Pilie, P. G.
    Aparicio, A.
    Logothetis, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S538 - S538
  • [38] Chromosomal instability (CIN) in circulating tumor cells (CTC) predicts for taxane sensitivity in metastatic castration-resistant prostate cancer (mCRPC).
    Keegan, Niamh M.
    Arfe, Andrea
    Barnett, Ethan
    Cohn, Erica Dayan
    Zhao, Jimmy
    Carbone, Emily
    Zanone, Michelle
    Anderson, Amanda
    Wenstrup, Rick
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] Circulating tumor DNA fraction (ctDNA) as a surrogate predictive biomarker in metastatic castration-resistant prostate cancer (mCRPC).
    Conteduca, Vincenza
    Wetterskog, Daniel
    Scarpi, Emanuela
    Romanel, Alessandro
    Gurioli, Giorgia
    Jayaram, Anuradha
    Lolli, Cristian
    Schepisi, Giuseppe
    Casadei, Chiara
    Menna, Cecilia
    Wingate, Anna
    Demichelis, Francesca
    De Giorgi, Ugo
    Attard, Gerhardt
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Optimal sequencing of enzalutamide and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC)
    Maughan, Benjamin Louis
    Suzman, Daniel L.
    Nadal, Rosa Maria
    Bassi, Sunakshi
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345